BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Nastech Pharmaceutical

Nastech Pharmaceutical Company Inc. is a Formulation Science specialty company that utilizes biophysics, physical chemistry and pharmacology to bridge the gap between drug discovery and drug optimization.Nastech’s proprietary Systemic Transnasal Absorption Technology (STA-T™), Paracellular Transport System (PTS™), and Junction Activator Technology (JAT™) provide rapid assessment of the merits of a drug compound for intranasal drug delivery. The Company has a diverse product portfolio across multiple therapeutic areas, including products targeted for the treatment of sexual dysfunction, pain management, cancer and hepatic illnesses, growth deficiency and multiple sclerosis. Nastech is broadening applications for its technology through an aggressive pre-clinical and clinical program involving the intranasal delivery of large-molecule drugs.


Contact Details:
3830 Monte Villa Parkway
Bothell
Washington
98021
United States of America
Tel:425-908-3600
Fax:425-908-3650
Email:ir@nastech.com
WWW:

www.nastech.com/




Loading...

Recent Publications by Nastech Pharmaceutical:

Discovery of tight junction modulators: significance for drug development and delivery.
Tight junction biology has many important applications, from improving...
20th September, 2008
Nastech Pharmaceutical Company, Inc., 3830 Monte Villa Parkway, Bothell, Drug Discov Today. 2008 Mar;13(5-6):261-7. Epub 2008 Feb 20.
DOI Direct Link
Identification of tight junction modulating lipids.
Tight junctions (TJs) play an important role in regulating paracellular...
20th June, 2008
Nastech Pharmaceutical Company, Inc., 3830 Monte Villa Parkway, Bothell, J Pharm Sci. 2008 Jun 18.
DOI Direct Link
A potential treatment for pandemic influenza using siRNAs targeting conserved regions of influenza A.
BACKGROUND: The recent emergence of avian H5N1 influenza virus has led to...
22nd April, 2008
Nastech Pharmaceutical Company, Inc., 3830 Monte Villa Parkway, Bothell, Expert Opin Biol Ther. 2008 Mar;8(3):299-313.
DOI Direct Link
Phage display screening of epithelial cell monolayers treated with EGTA: identification of peptide FDFWITP that modulates tight junction activity.
Phage display was used to screen for peptides that modulate the activity...
5th April, 2008
Nastech Pharmaceutical Company, Inc., Bothell, Washington 98021, USA. J Biomol Screen. 2007 Dec;12(8):1092-101. Epub 2007 Nov 26.
DOI Direct Link
Intranasal delivery: physicochemical and therapeutic aspects.
Interest in intranasal (IN) administration as a non-invasive route for...
3rd August, 2007
Nastech Pharmaceutical Company, Inc., Bothell, WA 98021, USA. Int J Pharm. 2007 Jun 7;337(1-2):1-24. Epub 2007 Mar 25.
DOI Direct Link

View more Nastech Pharmaceutical research publications.

BioNews Results for Nastech Pharmaceutical:

Examine the World Intranasal Drug Delivery Market
TMC Net:  Oct 1 2008 11:08PM Matching: nastech pharmaceutical
Examine the World Intranasal Drug Delivery Market
Calibre Macro World:  Oct 1 2008 7:11PM Matching: nastech pharmaceutical
Examine the World Intranasal Drug Delivery Market
Houston Chronicle:  Oct 1 2008 7:59PM Matching: nastech pharmaceutical
Examine the World Intranasal Drug Delivery Market
Yahoo! Canada:  Oct 1 2008 7:30PM Matching: nastech pharmaceutical
Examine the World Intranasal Drug Delivery Market
Market Wire:  Oct 1 2008 7:24PM Matching: nastech pharmaceutical
Promote your company here: BioNewsCast - Press Release Distribution

View more Nastech Pharmaceutical news.

Nastech Pharmaceutical Patents:

US Patent No.Title
7329725 Phage displayed Trp cage ligands
6436950 Nasal delivery of apomorphine
6225343 Compositions and methods comprising morphine gluconate
5874450 Intranasal formulations for promoting sleep and method of using the same
5770618 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom

View more Nastech Pharmaceutical patents.

Nastech Pharmaceutical (NSTK) Financial information Links from Barchart

NSTK Quote from from Barchart.com
NSTK Chart from from Barchart.com
NSTK Profile from from Barchart.com
NSTK Opinion from from Barchart.com

View more Nastech Pharmaceutical finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 236 times since April 2007, the link to the organisation's website has been followed 45 times

Recent Search Terms used to find this page: nasal delivery | nastech | FDFWITP | Nastech VAT | Nastech STA-T | .

Search for more companies in Bothell

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Nastech Pharmaceutical
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.